-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
-
Cosmetic Ingredient
- Water Treatment Chemical
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
On December 8, the stock price of Muyuan shares closed at 51.
After the stock price plummeted on December 7, Muyuan shares stopped falling on December 8 but rose instead
On December 7th, in a conference call organized by a listed company, Muyuan responded to many hot issues, including the impact of overdue bills on the company’s financing, the basis for applying for a credit line of 70 billion yuan next year, and the current progress of the financial company’s preparations, etc.
Muyuan shares stated that the main reason why a small number of commercial invoices were not paid in time by a few subsidiaries of the company was management issues
Up to now, the overdue bills have not had a substantial impact on Muyuan’s financing business
What is the basis for applying for a credit line of 70 billion yuan next year?
"After deliberation and approval by the board of directors and the general meeting of shareholders, the company’s total credit limit applied for in 2021 is 65 billion yuan.
At the same time, Muyuan also revealed that “the financial company is still in the process of preparing for establishment and has not yet been submitted to the China Banking and Insurance Regulatory Commission for approval
Muyuan Co.
"The company is more optimistic about the downward trend in costs next year